, Tracking Stock Market Picks
Enter Symbol:
Impax Laboratories, Inc. (IPXL) [hlAlert]

down 15.05 %

Impax Laboratories, Inc. (IPXL) downgraded to Hold with price target $17 by Jefferies

Posted on: Tuesday,  Sep 14, 2010  9:25 AM ET by Jefferies

Jefferies rated Hold Impax Laboratories, Inc. (NASDAQ: IPXL) on 09/14/2010. Previously Jefferies rated Buy Impax Laboratories, Inc. (NASDAQ: IPXL) on 05/18/2010.,
when the stock price was $20.19. Since then, Impax Laboratories, Inc. has lost 15.06% as of 09/14/2010's recent price of $17.15.
If you would have followed the previous Jefferies's recommendation on IPXL, you would have lost 15.05% of your investment in 119 days.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the Company focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system (CNS), disorders. Its brand-name product portfolio consists of development-stage projects to which it is applying its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceutical Division (Impax Division).

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/14/2010 9:25 AM Hold
17.15 17.00
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD down  -15.05 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/18/2010 9:25 AM Buy
20.19 24.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy